首页> 外文期刊>British Medical Journal >Reforming clinical research and development in England
【24h】

Reforming clinical research and development in England

机译:改革英格兰的临床研发

获取原文
获取原文并翻译 | 示例
       

摘要

Almost 80% of Department of Health's research and development funding is allocated to NHS trusts, limiting the department's ability to set strategic direction Radical overhaul of strategy, delivery systems, and funding streams aims to bring more non-governmental funding into all aspects of healthcare research Research strategy is being developed through new networks and bodies between NHS, academia, industry, and the voluntary sector Accountability arrangements for the work of the networks and bodies is complex and unclear NHS funding will be allocated through two new funding streams: support for science and NHS priorities and needs Several issues arise from the strategy, most notably the potential for conflicts of interest.
机译:卫生部将近80%的研究与开发资金分配给NHS信托基金,从而限制了该部门制定战略方向的能力。彻底改革战略,提供系统和资金流的目的在于将更多的非政府资金用于医疗保健研究的各个方面正在通过NHS,学术界,工业界和志愿部门之间的新网络和机构来制定研究策略,这些网络和机构的工作的责任安排很复杂,不清楚的NHS资金将通过两个新的资金流来分配:对科学和技术的支持。 NHS的优先事项和需求该战略产生了几个问题,最显着的是潜在的利益冲突。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号